News Focus
News Focus
icon url

frrol

09/30/14 8:13 PM

#71934 RE: Dr Jerry #71929

Thanks. Brilacidin seems to have such enormous advantages over all competing antibiotics, even these most recent compounds.
icon url

CallMeCrazy

09/30/14 9:50 PM

#71960 RE: Dr Jerry #71929

Yes B is superior to both, but what I found interesting was that this study compared tedizolid aka Sivextro made by Trius Therapeutics to linezolid aka Zyvox made by Pfizer, and the study was funded by Cubist Pharmaceuticals, the maker of Cubicin aka daptomycin.

What is Cubist up to? Could this be an attempt to slow the approach of bacterial resistance to Cubicin? Hmmm.

http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(14)70737-6/abstract